GSE99466
NFATC2 knock-down on melanoma cell line A375
RNA-seq on NFATC2 knock-down (siRNA) on melanoma cell line A375 Overall design: RNA-seq on the melanoma cell line A375 under two treatment conditions: NFATC2 siRNA and non-targeting control siRNA